What Is a Regulatory Binder in Clinical Research?
A regulatory binder is a centralized collection of essential clinical trial documents used to support regulatory compliance, inspection readiness, and Good Clinical Practice (GCP) standards throughout a research study.
Also referred to as an investigator binder or study binder, the regulatory binder helps sponsors, investigators, clinical research coordinators, and monitors organize critical documentation related to protocol oversight, informed consent, safety reporting, institutional review board (IRB) approvals, and investigator qualifications.
How regulatory binders support inspection readiness
Well-maintained regulatory binders help research sites prepare for sponsor audits, FDA inspections, IRB reviews, and monitoring visits by ensuring essential clinical trial documentation is complete, organized, and easily accessible.
A comprehensive regulatory binder helps demonstrate compliance with Good Clinical Practice (GCP), study protocols, informed consent requirements, safety reporting obligations, and investigator oversight responsibilities throughout the clinical trial lifecycle.
Checklist: What documents should be included in a regulatory binder?
The following checklist offers a framework for managing all necessary documents efficiently and will help demonstrate the investigator, and compliance with GCP and regulatory requirements.
| Document Category | Purpose | Examples / Documents |
| Protocol and amendments | To document revisions of trial-related documents during the trial | Log of protocol changes, IRB-approved protocol with principal investigator (PI) signature page, IRB-approved case report forms, IRB-approved advertisements and participant information sheets, protocol amendments |
| Informed consent documents | To document the informed consent | Log of informed consent versions, IRB-approved informed consents |
| IRB documentation | To document the trial has been subject to IRB review and approval | IRB federal assurance number, updated IRB roster, IRB approval letters, submissions, and correspondence including initial review, continuing review, advertisements, subject compensation, and other reporting requirements |
| Investigator qualification documentation | To document qualifications and eligibility to conduct the trial | Updated investigator CVs (signed/dated within two years), clinical licenses for PI and co-investigators, training certificates |
| Clinical investigator’s brochure | To document relevant and current scientific information for the investigational product has been provided | Investigator’s brochure or package insert for approved medications |
| FDA documents (if applicable) | To document the investigator’s agreement to conduct the study according to the protocol and GCP | FDA Forms 1571 and 1572, sample labels for investigational products, regulatory approval or authorization, FDA correspondence log |
| Financial disclosure forms | To document compliance with FDA regulations regarding financial interests | Signed forms for PI and co-investigators |
| Study communication | To document important decisions and agreements | Confidentiality agreement, data sharing agreement, material transfer agreement, signed agreements between sponsors and investigators, important decisions or notes to the study file |
| Delegation of authority log | To document which study-related tasks the PI has delegated to others | Delegation of authority log, signature form |
| Clinical research and study training | To document adequate training for all staff participating in the study | Documentation of training (e.g., human subject protection, GCP) |
| Screening/Enrollment log | To document identification of subjects who entered pre-trial screening and those who were enrolled | Log of screened subjects without identifying information, subject identification code list (kept separately) |
| Signed consent documents | To document informed consent | Signed informed consent documents |
| Study product records | To document the disposition and accountability of study products | Documentation of study product disposition and accountability |
| Laboratory certification | To document the competence of the facility performing protocol-specific tests | CLIA, CAP, or other certifications, updated normal-range values for reference labs |
| Specimen Tracking Log | To document the tracking and handling of specimens | Specimen tracking logs |
| Serious adverse events (SAEs)/Unanticipated problem documents | To document the sponsor was notified of all SAEs and related reports | SAE report forms, unanticipated problem forms, investigational new drug (IND) safety reports |
| Protocol deviation form or memo | To document any deviations from the protocol | Protocol deviation forms or memos |
| Clinical site monitoring visits | To document site visits and monitor findings | Site visit log, reports, and correspondence |
| Sponsor correspondence | To document agreements or significant discussions regarding trial administration | Sponsor correspondence |
| Data and safety monitoring documents | To document compliance and actions related to safety monitoring | Data and safety monitoring plan, reports generated for independent safety monitor(s), safety monitor meeting minutes |
| Other documents | To document additional relevant information and procedures | Unmasking procedures for blinded trials, certificate(s) of confidentiality |
Download a Printable Version of this Checklist
How can eRegulatory systems improve regulatory binder management?
Maintaining a complete and organized regulatory binder is an essential part of clinical trial management and regulatory compliance. Well-managed regulatory binders help research teams document study oversight, participant protections, investigator qualifications, and safety reporting while supporting audit readiness and efficient clinical trial operations.
Streamline regulatory compliance with Advarra’s eReg solution
Advarra’s electronic regulatory system (eReg) simplifies the management of essential documents, ensuring your clinical trials remain compliant and organized. This system provides key benefits to binder management such as:
- 21 CFR Part 11-compliant electronic signatures: Save time routing for signatures while ensuring compliance
- Mobile signing: Staff can sign documents from their phones, no matter where they are
- Electronic delegation of authority: Maintain a comprehensive and compliant delegation of authority log within eReg
- Regulatory templates: Save time and eliminate redundant workflows with predefined templates for each new protocol
- Standard operating procedure (SOP) management: Store and easily access SOPs in a central location
- Email integration: Input documents easily and forward email correspondence directly into the system
- IND storage: Manage IND documentation efficiently
- Review sessions: Grant limited eReg access for internal and external monitors for easier document review
Key takeaways about regulatory binders
- Regulatory binders support regulatory compliance, inspection readiness, and study oversight.
- Common regulatory binder documents include IRB approvals, informed consent forms, FDA forms, and delegation logs.
- Research sites use regulatory binders to prepare for audits, monitoring visits, and regulatory inspections.
- eReg can streamline document management and improve operational efficiency.
Additional Resources
Key clinical research definitions
- Regulatory Binder: A collection of essential clinical trial documents maintained to demonstrate compliance with regulatory requirements and CGP.
- Investigator Binder: Another term commonly used to describe a regulatory binder maintained at the research site.
- eReg: An electronic platform used to organize and manage clinical trial regulatory documents.
- Delegation of Authority Log: A document showing which study-related responsibilities were delegated by the principal investigator.
Guidance documents
- ICH GCP E6 Section 8: Specifies essential documents and their purposes
- ICH GCP E6 4.9.4: Guidelines for maintaining trial documents to prevent accidental or premature destruction
For more information, you can download our eBook detailing GCP and its role in the clinical research ecosystem.
